Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has submitted to BSE and NSE copies of newspaper clippings containing its unaudited financial results for the quarter ended 30 June 2025. The results were approved by the Board in its meeting held on 12 August 2025 and published on 14 August 2025 in Free Press (Mumbai and Indore editions) in English and Choutha Sansar in Hindi, with a QR code linking to the full results. The filing is a routine compliance submission under SEBI LODR Regulation 47, and the complete results are also available on the company's website (www.biofilgroup.net) and on the BSE/NSE websites. No specific Q1 financial numbers for Biofil are clearly extractable from the OCR text, as the scanned newspaper content is garbled and intermixed with results of other companies (Empire Industries, Grand Foundry, Daikaffil Chemicals, Deutsche Investments, Ironwood Education) that appeared on the same newspaper page.
This is a routine regulatory disclosure with no material new information for shareholders — the underlying Q1 FY26 numbers were already announced when the Board approved them on 12 August 2025. No immediate stock price impact is expected from this filing itself.